Study: NCT02375100

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Spinal Anesthesia
Description: All patients will be administered 3ml of %0.5 bupivacaine through L3-L4 interspace to acquire motor and sensory blockade

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Spinal Anesthesia
Description: All patients will be administered 3ml of %0.5 bupivacaine through L3-L4 interspace to acquire motor and sensory blockade

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Spinal Anesthesia
Description: All patients will be administered 3ml of %0.5 bupivacaine through L3-L4 interspace to acquire motor and sensory blockade

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transversus Abdominis Plane Block
Description: Analgesic intervention which will be performed only to Transversus Abdominis Plane Block arm. It requires 20ml of %0.25 bupivacaine administration through a 22 G. x 4 in. (100 mm) Insulated Echogenic Needle with 30° Bevel from midaxillary line between costal margin and anterior superior iliac spine with ultrasound guidance

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ilioinguinal Nerve Block
Description: Analgesic intervention which will be performed only to Ilioinguinal Nerve Block arm. It requires 10ml of %0.25 bupivacaine administration through a 22 G. x 3-1/8 in. (80 mm) Insulated Echogenic Needle with 30° Bevel between umbilicus and iliac crest where the nerve is detected with ultrasound guidance

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine %0.5 (hyperbaric)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine %0.5 (hyperbaric)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine %0.5 (hyperbaric)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine %0.25 (isobaric)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine %0.25 (isobaric)

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 25G Quincke needle

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 25G Quincke needle

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 25G Quincke needle

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Echogenic Needle with 30° bevel

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Echogenic Needle with 30° bevel

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Description: Analgesic drug administration through iv and im route postoperatively. Patients are administered iv acetaminophen 1g twice a day routinely

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetaminophen
Description: Analgesic drug administration through iv and im route postoperatively. Patients are administered iv acetaminophen 1g twice a day routinely

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Description: Analgesic drug administration through iv and im route postoperatively. Patients are administered iv acetaminophen 1g twice a day routinely

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tramadol
Description: Patients will be administered tramadol in postoperative period when their pain score exceeds 4 points (moderate pain)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tramadol
Description: Patients will be administered tramadol in postoperative period when their pain score exceeds 4 points (moderate pain)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tramadol
Description: Patients will be administered tramadol in postoperative period when their pain score exceeds 4 points (moderate pain)